Companies: 49,247 Total Market Cap: 132748422762186.78

Egyptian International Pharmaceutical Industries Company

EGX-PHAR
Pharmaceutical Preparations
Rank #21783
Market Cap 144.14 M
Volume 83,849
Price 0.97
Change (%) 0.20%
Country or region Egypt Egypt

Egyptian International Pharmaceutical Industries Company's latest marketcap:

144.14 M

As of 05/21/2025, Egyptian International Pharmaceutical Industries Company's market capitalization has reached $144.14 M. According to our data, Egyptian International Pharmaceutical Industries Company is the 21783th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 144.14 M
Revenue (ttm) 163.89 M
Net Income (ttm) 15.85 M
Shares Out 148.76 M
EPS (ttm) 0
Forward PE 7.24
Ex-Dividend Date 04/22/2025
Earnings Date 05/25/2025
Market Cap Chart
Data Updated: 05/21/2025

Egyptian International Pharmaceutical Industries Company's yearly market capitalization.

Egyptian International Pharmaceutical Industries Company has seen its market value grow from 4.31 B EGP to 7.38 B EGP since 2020, representing a total increase of 71.20% and an annual compound growth rate (CAGR) of 13.04%.
Date Market Cap(EGP) Change (%)
05/21/2025 7.38 B 8.84%
12/31/2024 6.83 B 25.78%
12/31/2023 5.43 B 49.96%
12/29/2022 3.62 B -12.86%
12/30/2021 4.16 B -3.57%
12/31/2020 4.31 B

Company Profile

About Egyptian International Pharmaceutical Industries Company

Egyptian International Pharmaceutical Industries Company (EIPICO) is a leading pharmaceutical manufacturer specializing in the production of pharmaceutical ampoules. Established in 1980 and headquartered in 10th of Ramadan City, Egypt, the company serves both domestic and international markets.

Product Portfolio

EIPICO offers a diverse range of pharmaceutical products, including:

  • Analgesics & Antipyretics – Pain and fever relief medications
  • Anti-Infectives – Treatments for bacterial and viral infections
  • Cardiovascular & Metabolic – Solutions for heart and metabolic disorders
  • Corticosteroids – Anti-inflammatory and immune-modulating drugs
  • Gastrointestinal Tract – Digestive health medications
  • Nervous System – Neurological and psychiatric treatments
  • Ophthalmic – Eye care solutions
  • Respiratory – Treatments for asthma and respiratory conditions
  • Topical Ointments & Creams – Dermatological products
  • Vitamins – Nutritional supplements
  • Miscellaneous – Additional specialized medications

Global Reach

In addition to serving the Egyptian market, EIPICO exports its high-quality pharmaceutical products to international markets, reinforcing its reputation as a trusted healthcare provider.

Frequently Asked Questions

As of 05/21/2025, Egyptian International Pharmaceutical Industries Company (including the parent company, if applicable) has an estimated market capitalization of $144.14 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Egyptian International Pharmaceutical Industries Company global market capitalization ranking is approximately 21783 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Egypt
Founded 1980
IPO Date n/a
Employees n/a
CEO Ahmed Saeed Killani
Sector
Industry Pharmaceutical Preparations
Address First Industrial Zone B1
10th of Ramadan City
Egypt
Website https://www.eipico.com.eg
People Also Watch
Ipsen S.A.
138.71 0.20%
Krka, d. d.
210.69 0.20%
BUD-RICHTER
29.22 0.20%
Hugel
262.42 0.20%